Astellas And UMN Complete Phase III Of Cell Cultured Influenza Vaccine Trial For Non-Elderly In Japan
This article was originally published in PharmAsia News
Executive Summary
Astellas and UMN have completed the vaccination of non-elderly patients in Phase III trials with their jointly developed cell cultured influenza HA vaccine ASP7374.